ACADIA Pharmaceuticals Inc. (ACAD) CEO Stephen Davis on Q1 2022 Results - Earnings Call Transcript

May 04, 2022 10:35 PM ETACADIA Pharmaceuticals Inc. (ACAD)
SA Transcripts profile picture
SA Transcripts

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET

Company Participants

Mark Johnson - VP, IR

Stephen Davis - CEO

Brendan Teehan - COO and Head, Commercial

Mark Schneyer - CFO

Serge Stankovic - President

Conference Call Participants

Charles Duncan - Cantor Fitzgerald

Neena Bitritto-Garg - Citi

Gregory Renza - RBC Capital Markets

Yatin Suneja - Guggenheim Partners

Sumant Kulkarni - Canaccord

David Hoang - SMBC

Rudy Li - SVB Securities

Chris Howerton - Jefferies

Vamil Divan - Mizuho Securities

Alex Thompson - Stifel

Jay Olson - Oppenheimer

Esther Hong - Berenberg


Good day, ladies and gentlemen, and welcome to ACADIA Pharmaceuticals First Quarter 2022 Financial Results Conference Call. My name is Crystal and I'll be your coordinator for today. [Operator Instructions]

I would now like to turn the presentation over to Mark Johnson, Vice President of Investor Relations at Acadia. Please proceed.

Mark Johnson

Good afternoon and thank you for joining us on today's call to discuss Acadia's first quarter 2022 financial results.

Joining me on the call today from ACADIA are Steve Davis, our Chief Executive Officer who will provide an overview of our first quarter performance and a review of our business. Following Steve, Brendan Teehan, our Chief Operating Officer, Head of Commercial will provide updates on our commercial performance and initiatives; Dr. Serge Stankovic, our President, will then discuss our pipeline progress. Finally, Mark Schneyer, our Chief Financial Officer, will discuss our financial results and guidance before turning it back to Steve for final remarks and opening up the call for your questions.

I would also like to point out that we are using supplement slides which are available on the Events and Presentation section of our website. Before we proceed, I would first like to remind you that during our

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.